Position in ABBV
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$6,010,924
+$1,654,817 QoQ
Shares Held
23,887
+19.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#1,201
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pure Financial Advisors, LLC holds $38,114,911 across 13 Drug Manufacturers - General names. ABBV ranks #4 (15.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,010 | $8,408,005 | |
| 2 | MRK |
Merck & Co., Inc.
|
59,640 | $7,663,740 | |
| 3 | JNJ |
Johnson & Johnson
|
29,199 | $7,415,670 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
23,887 | $6,010,924 | |
| 5 | AMGN |
Amgen Inc
|
7,972 | $2,886,820 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
22,483 | $1,295,470 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,775 | $982,293 | |
| 8 | NVO |
Novo Nordisk A S
|
16,779 | $804,385 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,010,924 | 23,887 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $4,356,107 | 20,029 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $4,119,674 | 18,030 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $2,390,650 | 10,325 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $1,775,269 | 9,564 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $1,577,476 | 7,529 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,311,426 | 7,380 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $1,380,582 | 6,991 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $3,103,482 | 18,094 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $3,384,692 | 18,587 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $2,846,488 | 18,368 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $2,703,203 | 18,135 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $2,387,280 | 17,719 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $2,755,985 | 17,293 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $2,609,516 | 16,147 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $2,197,688 | 16,375 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $2,755,348 | 17,990 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $2,862,214 | 17,656 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $2,373,155 | 17,527 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $1,859,355 | 17,237 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $1,906,544 | 16,926 | Shares | Sole | 2021-07-09 | |
| 2021-03-31 | $1,843,311 | 17,033 | Shares | Sole | 2021-04-09 | |
| 2020-12-31 | $1,811,692 | 16,908 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $1,478,344 | 16,878 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $1,594,541 | 16,241 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $924,946 | 12,140 | Shares | Sole | 2020-04-07 | |
| No filing history on record for this holder in this stock. | ||||||